HomeCancerProstate

Prostate

Prostate

FDA Approves FoundationOne Liquid CDx for Niraparib/Abiraterone in Aggressive Prostate Most cancers

Editor -
Prostate most cancers beneath the microscope: © heitipaves - inventory.adobe.comFoundationOne Liquid CDx is now an FDA-approved companion machine for niraparib (zejula) and abiraterone...
Prostate

Reworking Prostate Most cancers Care By means of Customized Medication

Editor -
Adam Weiner, MD, a urologic oncology fellow on the College of California, Los Angeles, discusses his journey towards changing into an oncologist, highlighting...
Prostate

Dr. Stratton on part 1B trial of relugolix and enzalutamide in high-risk prostate most cancers

Editor -
On this video, Kelly L. Stratton, MD, FACS, provides an summary of a part 1B trial evaluating relugolix (Orgovyx) and enzalutamide (Xtandi) for...
Prostate

AI-Assisted Contours Superior to Cognitively Outlined Prostate Most cancers Contours

Editor -
WEDNESDAY, July 3, 2024 (HealthDay Information) — Synthetic intelligence (AI)-assisted definition of prostate most cancers contours reduces underestimation of the extent of prostate...
Prostate

$1.6B might await Orion in up to date Merck prostate most cancers deal

Editor -
Merck & Co. Inc. is getting the unique, world rights from Orion Corp. to develop the oral prostate remedy, ODM-208, which the 2...
1...828384...89Page 83 of 89

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.